Enhypen's new album to be led by 'Sweet Venom'
Enhypen will continue its serenade of love with "Sweet Venom," the track leading the group's new EP, "Orange Blood."
The boy band's agency Belift Lab on Monday released the track list for the upcoming album.
"Sweet Venom" picks up the story from the band's previous title song, "Bite Me," which fronted the EP, "Dark Blood." The song tells of a boy's promise of love, which is so strong that not even the lethal poison seeping through his body can stop him from standing by "you." In the song, "you" refers to the boy's lover.
"Sweet Venom" is set to come in three different versions. Along with the main Korean edition, in which member Jay played a part in penning the words, an English version and a special collaborative version sung with American singer Bella Porch will present a variety of sounds for global fans to enjoy. The collaborative version with Porch will only be released digitally.
Enhypen is set to release "Orange Blood," its fifth EP, on Nov. 17.
The album extends the "blood" series kicked off by the band's previous album, "Dark Blood."
In the series' second chapter, the boy is enraptured by joy and love after reuniting with his lover, "you," and pledges to give his everything to be with her, the agency said in its statement Monday.
The album comes as part of the agency's efforts to foster what it refers to as "the next entertainment," which involves rolling out a diverse array of Enhypen content beyond just music.
Just as with "Dark Blood," the new album incorporates elements from the seven-member group's web-comic series, "Dark Moon: The Blood Altar," a fantasy-romance thriller inspired by and featuring the members.
The album's four side-tracks -- "Mortal," "Still Monster," "Far Away" and "Orange Flower (You Complete Me)" -- will each center around elements taken from the web-comic series' narrative, the firm added.
Star producers Slow Rabbit and Pdogg, who have created hits with famed K-pop musicians such as BTS and Tomorrow X Together, are also credited on the album. Slow Rabbit is credited on "Sweet Venom," while Pdogg is credited on "Still Monster."
Enhypen debuted in November 2020 under Belift Lab, a subsidiary label of BTS' company Hybe. The multinational team was formed through Hybe and Mnet's audition program, "I-Land."
A preview clip for "Orange Blood" will be released online Saturday.
(责任编辑:건강)
12일부터 4·10총선 예비후보자 등록 시작
Man nabbed in naked rampage
Seoul shares open sharply lower on US losses
S. Korea's Navy holds regular multinational mine warfare drills
G7 leaders strongly condemn N. Korea's satellite launch, arms transfers to Russia
- Moon officials tried to cover up North Korea’s murder of South Korean: state inspectors
- Coupang Play seeks turnaround with exclusive content
- Galleries vexed by outdated ban on taking older artwork out of country
- Seoul shares open sharply lower on US losses
- Seoul shares edge down amid US slowdown woes; won sharply down
- [view] 민심 더 싸늘해지는데…감동 없는 김기현 2기
- [Herald Interview] New Royal Salute makes grand debut to tap deeper into Korean whiskey market
- 'Teenage Mercenary’ leads Korean webtoon sensation in Japan
-
[KH Explains] China ups OLED ante to take over Korean shares
China’s recent move to ramp up investment in organic light-emitting display panels is stoking fears ...[详细]
-
Seoul shares close nearly flat on US rate
South Korean stocks finished almost flat Wednesday as better-than-expected US retail sales data spar ...[详细]
-
Posco International completes EV parts plant in Mexico
Posco International said Wednesday it completed a production facility for traction motor cores, or p ...[详细]
-
2023 Melon Music Awards to take place Dec. 2
Melon Music Awards, one of the nation's biggest music award shows, will take place on Dec. 2, i ...[详细]
-
Citibank Korea hosts digital forum for corporate clients
Citibank Korea on Wednesday shared insights on the digital market and presented overseas business op ...[详细]
-
Samsung Bioepis launches Soliris biosimilar in Europe
Samsung Bioepis, a biosimilar developer under Samsung Group, said Thursday that the company has comp ...[详细]
-
[KH Explains] Why Starbucks' new coupon policy is a big deal in Korea
Starbucks’ recent decision to allow customers to purchase items cheaper than the value of their coup ...[详细]
-
Seoul shares close nearly flat on US rate
South Korean stocks finished almost flat Wednesday as better-than-expected US retail sales data spar ...[详细]
-
Congresswoman redoubles calls for support to designate Nov. 22 as 'Kimchi Day'
A US congresswoman renewed calls Wednesday for support to designate Nov. 22 as "Kimchi Day," named a ...[详细]
-
Japan preparing to bring back some 20 S. Koreans from Israel, along with its own nationals: reports
Japan is preparing to take home about 20 South Koreans, along with its own nationals, on a special f ...[详细]
- Asiana Airlines to sell cargo biz to smooth merger
- Israeli military jets strike Gaza, says Hamas commander killed
- Blinken to discuss Russia, Middle East, N. Korea during visit to Seoul: State Department
- 美 ICBM '미니트맨
- Jungkook, Red Velvet, Stray Kids, new YG girl group among year
- US Fed keeps key lending rate unchanged for second consecutive time
- PPP decides to lift membership suspensions of ex
- JCS says N. Korea might have provided Russia with short
- Seoul shares shoot up nearly 2% on Fed's back
- J.Y. Park and Kim Wan
- LG Display to cut jobs in cost
- Samsung Bioepis launches Soliris biosimilar in Europe
- 김의겸 "김혜경 법카 유용 의혹, 그 정도 사안은 영장 못 쳐"
- Samsung Biologics expansion ahead of schedule
- Congresswoman redoubles calls for support to designate Nov. 22 as 'Kimchi Day'
- Muaz Razaq on being Muslim in South Korea
- Japan preparing to bring back some 20 S. Koreans from Israel, along with its own nationals: reports